What's new

Forbes puts Turkey-born biotech billionaire’s story on its cover

T-123456

MEMBER
Joined
Nov 13, 2012
Messages
11,579
Reaction score
11
Country
Turkey
Location
Netherlands
upload_2016-4-15_12-59-32.png


Forbes magazine has put the story of a Turkey-born biotech billionaire, Osman Kibar, who has been named the inventor of the “God Pill,” along with his company Samumed on its latest cover as one of the top 30 global game changers in the world.

“Samumed, the San Diego firm he [Kibar] has been stealthily building for a decade, is the most valuable biotechnology startup on the planet,” said the Forbes story.

Samumed, which is expected to soon be worth some $12 billion, is finding it easy to raise huge amounts of cash because it believes it has invented medicines that can reverse aging, according to the story. The company’s first drugs are targeted at specific organ systems. One aims to regrow hair for bald men. The same drug may also turn gray hair back to its original color, and a cosmetic version could erase wrinkles. A second drug seeks to regenerate cartilage in arthritic knees. Additional medicines in early human studies aim to repair degenerated discs in the spine, remove scarring in the lungs and treat cancer. After that, Samumed will attempt to cure a leading cause of blindness and go after Alzheimer’s, according to the Forbes story.

“The firm’s focus, disease by disease, symptom by symptom, is to make the cells of aging people regenerate as powerfully as those of a developing fetus,” it added.

Kibar, the founder and CEO of Samumed, was born in the Aegean province of İzmir and took his secondary education in Robert College, an Istanbul-based school that drew from among the top 0.2 percent of students who took Turkey’s national standardized test at age 11. Kibar, the grandson of a former İzmir mayor, later emigrated from Turkey to the U.S. for college. He took his graduate degrees in the U.S.

Kibar’s friends from Robert College have played a significant role in his success story. One of his friends from this school, Cevdet Samikoğlu, helped Kibar secure $3.5 million to create new startups. One, housed in a Pfizer incubator, was called Wintherix, which would eventually become Samumed.

Samikoğlu is now Samumed’s chief financial officer. Another Robert College pal, Yusuf Yazıcı, is now the company’s chief medical officer, while another, Arman Oruç, left a partnership at white-shoe law firm Simpson Thacher & Bartlett to become chief legal officer. Kibar, who is also a poker champion, works closely with Samumed’s chief scientific officer and cofounder, John Hood, who had invented a cancer drug that got his previous company, Targegen, bought by Sanofi for $635 million. Hood and Kibar have been going after a gene called Wnt, which stands for “wingless integration site.”

April/15/2016
http://www.hurriyetdailynews.com/fo...cover.aspx?pageID=238&nID=97852&NewsCatID=345

Someone to be proud of!!!!!
 
.
View attachment 300500

Forbes magazine has put the story of a Turkey-born biotech billionaire, Osman Kibar, who has been named the inventor of the “God Pill,” along with his company Samumed on its latest cover as one of the top 30 global game changers in the world.

“Samumed, the San Diego firm he [Kibar] has been stealthily building for a decade, is the most valuable biotechnology startup on the planet,” said the Forbes story.

Samumed, which is expected to soon be worth some $12 billion, is finding it easy to raise huge amounts of cash because it believes it has invented medicines that can reverse aging, according to the story. The company’s first drugs are targeted at specific organ systems. One aims to regrow hair for bald men. The same drug may also turn gray hair back to its original color, and a cosmetic version could erase wrinkles. A second drug seeks to regenerate cartilage in arthritic knees. Additional medicines in early human studies aim to repair degenerated discs in the spine, remove scarring in the lungs and treat cancer. After that, Samumed will attempt to cure a leading cause of blindness and go after Alzheimer’s, according to the Forbes story.

“The firm’s focus, disease by disease, symptom by symptom, is to make the cells of aging people regenerate as powerfully as those of a developing fetus,” it added.

Kibar, the founder and CEO of Samumed, was born in the Aegean province of İzmir and took his secondary education in Robert College, an Istanbul-based school that drew from among the top 0.2 percent of students who took Turkey’s national standardized test at age 11. Kibar, the grandson of a former İzmir mayor, later emigrated from Turkey to the U.S. for college. He took his graduate degrees in the U.S.

Kibar’s friends from Robert College have played a significant role in his success story. One of his friends from this school, Cevdet Samikoğlu, helped Kibar secure $3.5 million to create new startups. One, housed in a Pfizer incubator, was called Wintherix, which would eventually become Samumed.

Samikoğlu is now Samumed’s chief financial officer. Another Robert College pal, Yusuf Yazıcı, is now the company’s chief medical officer, while another, Arman Oruç, left a partnership at white-shoe law firm Simpson Thacher & Bartlett to become chief legal officer. Kibar, who is also a poker champion, works closely with Samumed’s chief scientific officer and cofounder, John Hood, who had invented a cancer drug that got his previous company, Targegen, bought by Sanofi for $635 million. Hood and Kibar have been going after a gene called Wnt, which stands for “wingless integration site.”

April/15/2016
http://www.hurriyetdailynews.com/fo...cover.aspx?pageID=238&nID=97852&NewsCatID=345

Someone to be proud of!!!!!


where do they work? in Turkey or US? I am not proud if it is in US
 
. .
Why do they prefer to call him "Turkey-born" instead of "Turk"? At first, I thought he is an American who borned in Turkey! But he (and most of his colleagues) is %100 Turk!

Well, USA offers more opportunities, so I wouldn't blame them for being there! But I hope they would also invest to their homeland with the billions they make! If they don't, I wouldn't be proud of them either!
 
. . . . . .
Abilerim, bu kadar basit bir meselede bile niye böyle birbirinizi yiyorsunuz anlamadım ki! Sorsan herkes kutuplaşmadan şikayetçi! Yapmayalım lütfen!

Gerçekten milyarlar kazandıysa gelsin bir kısmını ülkesinde ar-ge'ye yatırsın, hiç olmadı üniversitelere filan bağış yapsın! Gördüğüm kadarıyla üniversiteye kadar bu ülkenin nimetlerinden faydalanmış. Babası da eski İzmir belediye başkanıymış herhalde. Yani başarılarında Türkiye'nin ona sağladığı refahın payı da yadsınamaz!

Ama gelip tatil yapmaktan başka şu ülkeye para bırakmıyorsa, koy g... gitsin! Bu kadar basit, kavga edecek ne var?
 
.
Well, good for the guy, cover of forbes, making a lot of money on a potential that might come true and might not. If it does the effect will be very big, and people will probably stock up to look young the next 100 years.
 
.
That guy definitely doesn't look like the regular AKP supporter but like a well educated secular person with lot's of brain in his head... Too bad these people are an neglected minority in Turkey nowadays.
 
.
That guy definitely doesn't look like the regular AKP supporter but like a well educated secular person with lot's of brain in his head... Too bad these people are an neglected minority in Turkey nowadays.

How does a regular AKP supporter look like.
 
.
Like a guy from Eastern Turkey who is religious, darker- skinned, with a mustache, badly educated- haven't read a book in his life, having wet dreams with Erdogan every night.

I have my doubts, but it's okay.
 
.
Like a guy from Eastern Turkey who is religious, darker- skinned, with a mustache, badly educated- haven't read a book in his life, having wet dreams with Erdogan every night.
That's really racist and disgusting.
 
.

Country Latest Posts

Back
Top Bottom